The plan would also align Florida's prescription drug program with Trump Rx pricing standards to further reduce costs and expand access.
As governor, Byron Donalds will align Florida's prescription drug program with Trump Rx pricing standards.
Occurrences
Evidence
The official House site still identifies Byron Donalds as U.S. Congressman for Southwest Florida District 19 and shows ongoing congressional work, not any Florida executive action on prescription drug pricing.
TrumpRx currently advertises Most-Favored-Nation pricing and hundreds of generics, establishing the federal pricing standard the Florida promise references, but it does not show any Florida adoption by Donalds.
Florida's official Executive Office of the Governor page identifies Ron DeSantis as the 46th Governor of Florida and carried a June 30, 2026 featured news item from Governor DeSantis.
Donalds' official House site identifies him as Congressman Byron Donalds representing Southwest Florida District 19 and shows a current congressional vote record through June 29, 2026.
AP reported that U.S. Representative Byron Donalds announced a 2026 Florida gubernatorial campaign to succeed term-limited Governor Ron DeSantis.
Donalds' campaign site describes him as running for governor, states he is committed to implementing President Trump's agenda, and says the site is paid for by Byron Donalds, Republican, for Governor.
Donalds' health-cost issue page proposes posted provider prices, lowest negotiated rates for cash patients, prior-authorization deadlines, state enforcement, and PBM transparency for rebates and spread pricing.
Executive Order 14297 set a federal policy that Americans should have access to most-favored-nation prices and directed HHS to communicate price targets to drug manufacturers.
The TrumpRx.gov site advertises Most-Favored-Nation pricing, hundreds of generics, medication search, and examples of presidential deal prices.
Assessments
The promise is explicitly gubernatorial and prospective: Donalds would align Florida's prescription drug program with Trump Rx pricing standards as governor. As of July 1, 2026, the evidence shows Donalds is still a U.S. Representative and a candidate for Florida governor, while Ron DeSantis remains governor. TrumpRx/MFN pricing exists federally, but there is no evidence that Donalds has held the Florida executive office or implemented, sponsored, or materially advanced a Florida alignment policy. Because the relevant gubernatorial term has not occurred, this is not delivered but is better treated as unresolved rather than a final failed promise.
Byron Donalds is still serving in federal office as a U.S. Representative, and the evidence shows no Florida governorship or concrete state executive action aligning Florida's prescription drug program with TrumpRx pricing standards. The federal TrumpRx standard exists, but there is no sign Donalds implemented or materially advanced the promised Florida policy, so the promise was not fulfilled.